Mario De Bellis

Jan 29, 2024 | ejso.com | Mario De Bellis |Hepatobiliary Surgery |Alberto Contro |Andrea Bianco |Alfredo Guglielmi |Giancarlo Mansueto | +3 more

Recurrent or locally advanced peri-hilar cholangiocarcinoma (PHCC) usually involves the portal vein (PV) leading to significant stenosis. With disease progression, clinical symptoms such as ascites, bleeding, and hepatic insufficiency are usually observed. Little is know about the benefit of PV stenting in relieving the symptoms associated to portal hypertension and allowing anticancer therapies. The aim of this study is to review our experience in PV stenting for PHCC patients.